1. Regenerative Medicine Market - Market Overview
2. Executive Summary 
3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Regenerative Medicine Market- Market Forces
4.1. Drivers
4.1.1. Development of efficient and advance technology in tissue and organ regeneration
4.1.2. Growing funding from government and private organizations to support the development of regenerative medicines products
4.2. Restraints
4.2.1. Higher cost of research and development 
4.3. Opportunities
4.3.1. Emerging economies
4.4. Challenges
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Regenerative Medicine Market- Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Regenerative Medicine Market, By Therapy
6.1. Cell Therapy 
6.2. Gene Therapy 
6.3. Tissue Engineering 
6.4. Immunotherapy 
7. Regenerative Medicine Market, By Product
7.1. Autologous Cell-Based Products
7.2. Allogeneic Cell-Based Products
7.3. Acellular Products 
8. Regenerative Medicine Market, By Application 
8.1. Orthopedic & Musculoskeletal Spine 
8.2. Dermatology 
8.3. Cardiovascular 
8.4. Central Nervous System 
8.5. Oncology 
8.6. Diabetes 
8.7. Others
9. Regenerative Medicine Market, By Geography
9.1. Europe
9.1.1. Germany
9.1.2. France
9.1.3. Italy
9.1.4. Spain
9.1.5. Russia
9.1.6. U.K.
9.1.7. Rest of Europe
9.2. Asia Pacific
9.2.1. China
9.2.2. India
9.2.3. Japan
9.2.4. South Korea
9.2.5. Rest of Asia-Pacific
9.3. North America 
9.3.1. U.S.
9.3.2. Canada
9.3.3. Mexico
9.4. Rest of the World (RoW)
9.4.1. Brazil
9.4.2. Rest of RoW
10. Regenerative Medicine - Market Entropy
10.1. Expansion
10.2. Technological Developments
10.3. Merger & Acquisitions, and Joint Ventures
10.4. Supply- Contract
11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
11.1. Japan Tissue Engineering Co., Ltd
11.2. Vertex Pharmaceuticals Incorporated
11.3. Cytori Therapeutics Inc.
11.4. Celgene Corporation 
11.5. Acelity (KCI Licensing) 
11.6. Nuvasive, Inc. 
11.7. Organogenesis Inc.
11.8. Vericel Corporation 
11.9. Cytori Therapeutics Inc. 
11.10. Stemcells, Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer